GLP-1 receptor agonists have become a paradigm shift in treating the two conditions together, and clinical trials have shown an average of 15-22% body weight loss with recent preparations (semaglutide and tirzepatide)
[5] Melanotan-II may cause reversible darkening of moles and freckles
Bartl M, Xylaki M, Bhr M, Weber S, Trenkwalder C, Mollenhauer B
Despite their wide suitability, Hers or Hims might not be a good fit some
However, obesity also appears to play an independent role in CKD risk and progression by triggering increased inflammatory signaling, oxidative stress, and gut microbiome disturbance, as well as premature cellular aging and dysfunction